Nektar Therapeutics | NKTR - Market Capitalization


Nektar Therapeutics reported $15.95B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
ALKERMES USD 5.53B 909M May/2026
Alterity Therapeutics Limited AUD 40M 16M May/2026
Amgen USD 189.89B 13.64B Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cipla INR 1.22T 6.47B Dec/2025
Dr.Reddys Laboratories INR 1.06T 39.78B Dec/2025
Eisai JPY 1.31T 140.95B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Exelixis USD 12.9B 1.15B May/2026
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Neurocrine Biosciences USD 13.34B 800M May/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 148.08B 6.51B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Xencor USD 1.09B 256M Dec/2025